Results 71 to 80 of about 1,017,177 (255)
British Journal of Clinical Pharmacology, EarlyView.Abstract Aim Non‐surgical treatment of acute liver failure (ALF) is primarily supportive and depends on the underlying cause. While N‐acetylcysteine (NAC) is proven effective in paracetamol‐induced ALF, its potential benefits in non‐paracetamol ALF for paediatric patients remain unclear.
Alise D. E. de Groot +7 more
wiley +1 more source
REVIEW ARTICLE: DEVELOPEMENT AND USING DENGUE VACCINE FOR DENGUE INFECTION VIRUS
Medical and Health Science Journal, 2019 : Tropical and subtropical countries are regions with high incidence of dengue infection. Dengue virus infection is estimated to cause 300 million new infections in one year and approximately 1 million severe cases with 2 + 5% deaths.
Firdaus Kabiru Massey, Rika Yulia
doaj +1 more source
BMEMat, EarlyView.LSPR biosensing enables rapid, sensitive, and low‐sample‐volume detection of biomarkers, with broad applications in diagnosing cancer, infectious, and chronic diseases. Advances in nanostructure design, micro/nanofabrication, and microfluidic integration have expanded the potential of LSPR sensors in biomedical diagnostics.
Zhaoxin Geng +4 more
wiley +1 more source
Serotype and Clinical Performance of Dengue Virus Infection on the Year 2009
Indonesian Journal of Tropical and Infectious Disease, 2010 Dengue hemorrhagic fever is one of the important health problem in Indonesia, mortality rate is becoming decrease but many dengue shock syndrome cases is very difficult to be help.
Soegeng Soegijanto +3 more
doaj +1 more source
Reciprocal tripartite interactions between the Aedes aegypti midgut microbiota, innate immune system and dengue virus influences vector competence. [PDF]
PLoS Neglected Tropical Diseases, 2012 Dengue virus is one of the most important arboviral pathogens and the causative agent of dengue fever, dengue hemorrhagic fever, and dengue shock syndrome.
Jose Luis Ramirez +6 more
doaj +1 more source
Immature Dengue Virus: A Veiled Pathogen?
PLoS Pathogens, 2010 Cells infected with dengue virus release a high proportion of immature prM-containing virions. In accordance, substantial levels of prM antibodies are found in sera of infected humans. Furthermore, it has been recently described that the rates of prM antibody responses are significantly higher in patients with secondary infection compared to those with
Rodenhuis-Zybert, I.A. +6 more
openaire +7 more sources
The Medicinal Chemistry of Dengue Virus [PDF]
Journal of Medicinal Chemistry, 2016 The dengue virus and related flaviviruses are an increasing global health threat. In this perspective, we comment on and review medicinal chemistry efforts aimed at the prevention or treatment of dengue infections. We include target-based approaches aimed at viral or host factors and results from phenotypic screenings in cellular assay systems for ...
Mira A M, Behnam +3 more
openaire +2 more sources
Clinical Pharmacology &Therapeutics, EarlyView.Dengue virus (DENV) infection is a significant global health threat. Mosnodenvir (JNJ‐64281802) is a pan‐serotype small molecule antiviral blocking DENV replication. A Phase IIa study (NCT05048875) evaluated the antiviral activity, safety, and pharmacokinetics of mosnodenvir as prophylaxis against DENV‐3 in a controlled human infection model (CHIM).
Nele Goeyvaerts +8 more
wiley +1 more source
Dengue- und Chikungunya-Fieber in der Allgemeinpraxis [PDF]
, 2009 Quintessenz: Dengue und Chikungunya sind akute Viruserkrankungen mit hohem Fieber, Kopfschmerzen, Gliederschmerzen, Hautausschlägen, welche in zahlreichen Ländern des Südens sehr verbreitet sind und auch Touristen betreffen.
Blum, J., Hatz, C. F., Hatz, C, Blum, J
core +1 more source
Inflammasome Fuels Dengue Severity
Frontiers in Cellular and Infection Microbiology, 2020 Dengue is an acute febrile disease triggered by dengue virus. Dengue is the widespread and rapidly transmitted mosquito-borne viral disease of humans.
Gaurav Shrivastava +2 more
doaj +1 more source